Data / Form D filings / Aptinyx Inc.
Aptinyx Inc.: Form D filings
Aptinyx Inc., a pharmaceuticals company in Evanston, IL, filed 2 Form D notices with the SEC between 2016 and 2017. The latest, on December 21, 2017, reports $70 million sold of a $70 million offering to 63 investors.
Find out what Aptinyx Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1801 MAPLE AVENUE, SUITE 4300, Evanston, IL, 60201
- Phone
- (847) 871-0377
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2015
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1674365
The full lists. Form D filings in Illinois: 1,511 rows, $75.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 21, 2017 | New notice | $70,000,000 | $70,000,000 | $0 | 63 | Dec 15, 2017 | sec.gov |
| May 19, 2016 | New notice | $65,000,000 | $24,999,999 | $40,000,001 | 48 | May 4, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph R. Moskal | Executive Officer | |
| Terry P. Gould | Director | |
| Andrew D. Kidd | Executive Officer | |
| James P. Topper | Director | |
| Ashish M. Khanna | Executive Officer | |
| Torsten M. Madsen | Executive Officer | |
| Liam P. Ratcliffe | Director | |
| Adam M. Koppel | Director | |
| Wilbur H. Gantz III | Director | |
| Norbert G. Riedel | Executive Officer, Director | |
| Patrick H. Enright | Director |
Every Form D from the week of Dec 18, 2017 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Aptinyx Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.